DepoFoam® - About Depofoam®

DepoFoam^® is a proprietary, proven drug delivery technology platform that provides highly versatile, sustained-release delivery of medications. DepoFoam technology has been successfully used in products registered in a number of territories including the United States, European Union, Australia, New Zealand, and South America (DepoCyt^®, DepoCyte^® and DepoDur^®). We continue to expand our registration efforts worldwide for our current products.

DepoFoam consists of multi-vesicular liposome particles; numerous internal aqueous chambers contain the encapsulated drug.

Releases encapsulated drug over a desired period of time, from 1 to 30 days
- Without altering the current drug molecule
Utilizes a ready-to-use aqueous suspension
- Works with narrow gauge needles and pen systems (27-31 gauge)
Incorporates membrane components that are natural, well tolerated, and cleared by normal metabolic pathways
- Less than 3% lipid and is biodegradable and biocompatible
Offers flexible delivery that can be designed to offer an immediate release dose followed by sustained delivery

Proprietary proven delivery platform
Two products: worldwide registrations and supply
Manufactured and developed at Pacira's cGMP facilities for over 15 years
Ongoing technology enhancement programs